Recent Security Class Actions

Depomed, Inc. (NASDAQ: DEPO)

Company Name:Depomed, Inc.
Stock Symbol:NASDAQ: DEPO
Class Period Start:07/29/2015
Class Period End (inclusive):08/07/2017
Filing Deadline:10/17/2017

According to the law firm press release, Depomed, a specialty pharmaceutical company, engages in the development, sale, and licensing of products for pain and other central nervous system conditions in the United States. Among other drugs, Depomed’s portfolio includes the opioids Nucynta (tapentadol) and Lazanda (fentanyl).